Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 39 in last 24h · 115,255 total before filter · latest 2h ago

39last 24h

1801last 7d

299● bullish (7d)

170● bearish (7d)

205publishers

All Macro322 Earnings850 M&A104 Regulatory25 Product16 Analyst25

✕ clear all filtersticker: ARDXsentiment: bullishSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Zacks12d agobullish

Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates

Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +18.56% and +11.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ARDX

Insider Monkey77d agobullish

Should You Buy Ardelyx (ARDX)?

We just covered the Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot. Ardelyx Inc. (NASDAQ:ARDX) ranks #9 (see Claude Stock Portfolio: Top 5 Stocks to Buy According to AI Chatbot). Number of Hedge Funds: 30 Biotech company Ardelyx Inc. (NASDAQ:ARDX) is one of the recent additions in the Claude portfolio. Anthropic’s […]

ARDX

Zacks107d agobullish

Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of -15.39% and +3.24%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

ARDX